Therapeutic Area Lead, Alzheimer's Disease

ki:elements pioneers speech-based biomarkers as tools for clinical research. We are seeking a strategic and commercially minded Therapeutic Area Lead to guide the development positioning and market success of SB-C our speech biomarker for cognition.

This role combines product ownership with commercial leadership shaping the vision driving adoption and acting as the trusted external champion of SB-C across the Alzheimers disease and cognitive health ecosystem.

You will own the end-to-end strategy for SB-C: from defining the product roadmap and market fit to leading external engagement with pharma and biotech partners. You will be the bridge between science product and business ensuring SB-C continues to advance as the industrys most trusted digital cognitive assessment.

Tasks

• Define and own the strategic vision and roadmap for SB-C within Alzheimers disease and related cognitive disorders.
• Work closely with R&D data science clinical and regulatory teams to align technical development with customer and market needs.
• Translate market insights and clinical developments into product requirements and value propositions.
• Guide evidence-generation and validation strategies to strengthen product credibility and differentiation.
• Act as the primary commercial champion for SB-C representing the product externally with clients partners and industry bodies.
• Build and manage strategic partnerships with pharma biotech CROs and digital health collaborators deploying SB-C.
• Lead go-to-market planning pricing strategy and client engagement approaches.
• Support business development by articulating the clinical and commercial value of SB-C to prospective partners.
• Monitor competitive landscape and market trends in AD and digital biomarkers to identify growth opportunities.
• Serve as a trusted expert in cognition and Alzheimers disease supporting client implementation and ensuring scientific credibility.
• Collaborate cross-functionally across the organization to drive alignment and impact.
• Represent SB-C at key scientific and industry events publications and collaborations.

Requirements

• Advanced degree in neuroscience psychology pharmacology or a related field; MBA or equivalent commercial experience is an asset.
• Between 5 and 15 years of expertise in Alzheimers disease drug development cognitive assessment or biomarker strategy ideally with product or commercial exposure.
• Deep understanding of cognition clinical endpoints and the evolving biomarker landscape in neurodegenerative diseases.
• Strategic thinker with strong commercial acumen.
• Excellent communication and relationship-building skills.
• Comfortable operating at the interface of science and business.
• Experience engaging pharma or biotech partners is highly desirable.
• Up to 30% travel.

Benefits

• ki:elements offers a four-day workweek (100% 32 hours; Mo-Th)
• Remote (Europe & US East Coast preferred) or at our offices in Berlin & Saarbrücken.
• Be part of a pioneering company at the forefront of healthcare innovation.
• Work with a talented and passionate team dedicated to making a difference.
• 85.000 - 120.000 in full time (100%); part-time equivalent.

If our profiles match we would be delighted to hear from you. Please contact us with your resume and a brief note why we should work together in the future.